{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Soluble guanylate cyclase activators", "item": "https://www.patentleaderboard.com/patent/8741910"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble guanylate cyclase activators

Soluble guanylate cyclase activators

US Patent 8741910 · Granted Jun 3, 2014

Estimated economic value: $91,329,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors2024
Heteroaryl compounds useful as MK2 inhibitors2023
Biaryl monobactam compounds and methods of use thereof for the treatment of bact2022
Heteroaryl compounds useful as MK2 inhibitors2021
Heteroaromatic compounds useful for the treatment of proliferative diseases2021
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors2021
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in v2021
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors2021
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors2021
Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fib2021
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)2021
Inhibitors of cyclin-dependent kinase 7 (CDK7)2020